ABSTRACT
La incidencia de neoplasia de vulva ronda el 1-2 por 100 000 mujeres con predominancia en rangos etarios de diagnóstico entre los 65 -75 años. Este tipo de patología oncológica se aborda con técnicas quirúrgicas resumidas en vulvectomía simple o vulvectomía con linfadenectomía unilateral o bilateral según estadiaje de afectación cutánea. La morbilidad de este proceso quirúrgico se agrupa principalmente en la humedad cutánea, dehiscencia e infección. La utilización de Nobecutan® en aerosol como apósito plástico barrera disminuye la comorbilidad quirúrgica cutánea (AU)
The incidence of neoplasia of vulva round 1-2 per 100 000 women with predominance in ranges age of diagnosis between 65-75 years. This type of cancer pathology is tackled with surgical techniques summarized in simple vulvectomy or vulvectomy with unilateral or bilateral lymphadenectomy according to staging of cutaneous involvement. The morbidity of this surgical process is mainly grouped in skin moisture, dehiscence and infection. The use of Nobecutan® as a plastic dressing aerosol barrier reduces cutaneous surgical comorbidity (AU)
Subject(s)
Humans , Female , Wound Closure Techniques/instrumentation , Vulvar Neoplasms/surgery , Bandages , Surgical Wound Infection/prevention & control , Wound Healing/physiology , Lymph Node Excision , Postoperative Complications/prevention & controlABSTRACT
The incidence of neoplasia of vulva round 1-2 per 100,000 women with predominance in ranges age of diagnosis between 65-75years. This type of cancer pathology is tackled with surgical techniques summarized in simple vulvectomy or vulvectomy with unilateral or bilateral lymphadenectomy according to staging of cutaneous involvement. The morbidity of this surgical process is mainly grouped in skin moisture, dehiscence and infection. The use of Nobecutan® as a plastic dressing aerosol barrier reduces cutaneous surgical comorbidity.
